Cargando…

Targeting Splicing Factor SRSF6 for Cancer Therapy

Aberrant alternative splicing of pre-mRNA is an emerging cancer hallmark. Many cancer-associated genes undergo alternative splicing to produce multiple isoforms with diverse or even antagonistic functions. Oncogenic isoforms are often up-regulated, whereas tumor suppressive isoforms are down-regulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	She, Wenting, Shao, Jun, Jia, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669609/ https://www.ncbi.nlm.nih.gov/pubmed/34917618 http://dx.doi.org/10.3389/fcell.2021.780023

Ejemplares similares

SRSF10 is essential for progenitor spermatogonia expansion by regulating alternative splicing
por: Liu, Wenbo, et al.
Publicado: (2022)

ERK1/2-EGR1-SRSF10 Axis Mediated Alternative Splicing Plays a Critical Role in Head and Neck Cancer
por: Yadav, Sandhya, et al.
Publicado: (2021)

Targeting alternative splicing in cancer immunotherapy
por: Han, Nan, et al.
Publicado: (2023)

HIV-1 transcription is regulated by splicing factor SRSF1
por: Paz, Sean, et al.
Publicado: (2014)

Krüppel-Like Factor 6 Splice Variant 1: An Oncogenic Transcription Factor Involved in the Progression of Multiple Malignant Tumors
por: Hu, Kang, et al.
Publicado: (2021)

Splicing factor SRSF6 mediates pleural fibrosis
por: Liang, Li-Mei, et al.
Publicado: (2021)

THU550 The Splicing Factor SRSF6 Regulates Androgen Receptor Activity And Represents A Potential Therapeutic Target In Prostate Cancer
por: Luque, Raul M, et al.
Publicado: (2023)

AM1241-Loaded Poly(ethylene glycol)–Dithiothreitol Hydrogel Repairs Cranial Bone Defects by Promoting Vascular Endothelial Growth Factor and COL-1 Expression
por: Ai, Yilong, et al.
Publicado: (2022)

The role of KRAS splice variants in cancer biology
por: Nuevo-Tapioles, Cristina, et al.
Publicado: (2022)

m(6)A Modification in Mammalian Nervous System Development, Functions, Disorders, and Injuries
por: Yu, Jun, et al.
Publicado: (2021)

The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer
por: Cerasuolo, Andrea, et al.
Publicado: (2020)

Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells
por: Zhu, Jinshun, et al.
Publicado: (2021)

Pre-mRNA Processing Factors and Retinitis Pigmentosa: RNA Splicing and Beyond
por: Yang, Chunbo, et al.
Publicado: (2021)

Splicing factor SRSF6 promotes hyperplasia of sensitized skin
por: Jensen, Mads A., et al.
Publicado: (2014)

Amino Acid Transporter SLC6A14 (ATB(0,+)) – A Target in Combined Anti-cancer Therapy
por: Nałęcz, Katarzyna A.
Publicado: (2020)

SYMPK Is Required for Meiosis and Involved in Alternative Splicing in Male Germ Cells
por: Wu, Rui, et al.
Publicado: (2021)

Editorial: Targeted therapies for aggressive cancers
por: Lee, Sean B., et al.
Publicado: (2023)

Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies
por: Comunanza, Valentina, et al.
Publicado: (2017)

m(6)A Reader: Epitranscriptome Target Prediction and Functional Characterization of N(6)-Methyladenosine (m(6)A) Readers
por: Zhen, Di, et al.
Publicado: (2020)

The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer
por: Luo, Jiangti, et al.
Publicado: (2023)

Targeting Integrins for Cancer Therapy - Disappointments and Opportunities
por: Bergonzini, Cecilia, et al.
Publicado: (2022)

Editorial: Cell Death and Targeted Cancer Therapies
por: Bagci-Onder, Tugba, et al.
Publicado: (2022)

Editorial: PROTACs: Targeted therapies for cancer treatment
por: Tabassum, Sobia
Publicado: (2023)

Editorial: PROTACs: Targeted therapies for cancer treatment
por: Tabassum, Sobia
Publicado: (2023)

Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy
por: Yu, Yong, et al.
Publicado: (2023)

Pharmacological Targeting of STING-Dependent IL-6 Production in Cancer Cells
por: Al-Asmari, Sumaiah S., et al.
Publicado: (2022)

Alternative splicing in shaping the molecular landscape of the cochlea
por: Kim, Kwan Soo, et al.
Publicado: (2023)

New Insights Into Targeting Membrane Lipids for Cancer Therapy
por: Preta, Giulio
Publicado: (2020)

Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma
por: Sivasudhan, Enakshi, et al.
Publicado: (2021)

Cleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma
por: Chen, Shi-lu, et al.
Publicado: (2021)

Nucleo-cytoplasmic shuttling of splicing factor SRSF1 is required for development and cilia function
por: Haward, Fiona, et al.
Publicado: (2021)

Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy
por: Dai, Hong, et al.
Publicado: (2022)

Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers
por: Li, Yongshu, et al.
Publicado: (2022)

Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
por: Geng, Xinglong, et al.
Publicado: (2021)

Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets
por: Chen, Da-Hong, et al.
Publicado: (2021)

The Construction of Bone Metastasis-Specific Prognostic Model and Co-expressed Network of Alternative Splicing in Breast Cancer
por: Huang, Runzhi, et al.
Publicado: (2020)

CaMKIIδ Splice Variants in the Healthy and Diseased Heart
por: Duran, Javier, et al.
Publicado: (2021)

Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy
por: Xie, Bingteng, et al.
Publicado: (2022)

Temporal Dynamic Analysis of Alternative Splicing During Embryonic Development in Zebrafish
por: Liu, Zhe, et al.
Publicado: (2022)

A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer
por: Li, Qian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_njc8e5t8l4tmlmt37acbpf5ar2